Pioneering Psychiatric Surgery Worldwide

Around 30% of individuals with psychiatric conditions find that their symptoms resist treatment, leading to significant challenges in daily life. This medical resistance doesn't just affect the person but extends its impact globally, creating a sense of loss and frustration. People may feel isolated as they struggle with social interactions, education, and job opportunities, often leading to economic hardship. In their day-to-day lives, these individuals wrestling with untreated conditions can feel overwhelmed, anxious, and disconnected from the world around them, making even simple tasks daunting. The ripple effects on their families and communities can be profound, emphasizing the need for more effective treatment options and support systems.

Global Impact
Neuromodulation

Neuromodulation is proving to be an effective answer to drug-resistant psychiatric conditions such as major depressive disorder, bipolar disorder, anxiety disorder, post-traumatic stress disorder and obsessive-compulsive disorder. This innovative approach harnesses submilliamperic electrical impulses to modulate neural activity, providing a new therapeutic avenue for those who have not responded to traditional medications. Additionally, it is reversible, giving patients the freedom to choose their treatment path without long-term commitments.

Rationale

OCD (Obsessive-Compulsive Disorder)

DBS is a US FDA approved therapy for OCD, with more than 70% success in patients. This innovative treatment option provides hope for effective management of symptoms.

OCD Treatment

Innovative surgical protocols addressing severe OCD cases.

Chronic Anxiety Disorder

Research suggests that the right amygdala plays a crucial role in the processing of fear and anxiety-related stimuli. Furthermore, neuromodulation techniques, such as AMYGDALOGOMY, have shown potential in alleviating symptoms of anxiety disorder.

Experience Matters

Dr. Champaneri has pioneered amygdalotomy for PTSD and OCD, shaping psychiatric surgery worldwide with unmatched expertise.

Global leader in amygdalotomy.

Career

Clinical Director

Neuroexcellence Global

2015 - Present

Leading the psychiatric surgery program with a focus on precision and patient care.

Neurosurgeon

Global Neurosurgery Center

2008 - 2015

Developed advanced protocols for epilepsy and psychiatric neurosurgery.

Dr. Himanshu Champaneri performing a delicate amygdalotomy procedure in a state-of-the-art surgical suite.
Dr. Himanshu Champaneri performing a delicate amygdalotomy procedure in a state-of-the-art surgical suite.

Contact Us

Minimalist black and white illustration of a globe with connecting lines symbolizing global patient outreach.
Minimalist black and white illustration of a globe with connecting lines symbolizing global patient outreach.

Reach out anytime via WhatsApp or our sleek multilingual contact form.